Tabelecleucel

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Structurally Diverse
Source Materials Class	ORGANISM
Source Materials Type	ALLOGENIC HUMAN
Source Materials State	LIVE
Source Materials Parent	`G0T704E6Z3` HOMO SAPIENS WHOLE
Part	blood
Fraction Material Type	cells
Fraction Name	hla-typed ebv seropositive or primary stem cell donor t cells
Record UNII	G3NJ7M8N4H
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

Tabelecleucel

Official Name

English

ATA-129

Preferred Name

English

EBV-CTL

Code

English

ATA129

Code

English

Tabelecleucel [WHO-DD]

Common Name

English

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Classification Tree

Code System

Code

Designated

FDA ORPHAN DRUG

487015

Adoptive Cell Therapy Agent

NCI_THESAURUS

C28681

Positive

EU-Orphan Drug

EU/3/16/1627

Adoptive Cell Therapy Agent

NCI_THESAURUS

C129826

Showing 1 to 4 of 4 entries

Show entries

Code System

Code

Type

Description

FDA UNII

G3NJ7M8N4H

PRIMARY

NCI_THESAURUS

C143140

PRIMARY

USAN

DE-131

PRIMARY

SMS_ID

100000181002

PRIMARY

INN

10640

PRIMARY

Showing 1 to 5 of 5 entries

Show entries

Related Record

Type

Details


					YAY6AQ9GXY

EPSTEIN-BARR VIRUS INFECTED CELLS

TARGET->CYTOTOXIC T-CELL

Amount:

Showing 1 to 1 of 1 entries

Show entries

Related Record

Type

Details


					G3NJ7M8N4H

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Agent Modifications

Show entries

Modification Process	Modification Role	Modification Type	Amount	Fragment Name	Fragment ID
CULTURED	T-CELL STIMULATION	IMMUNOLOGICAL	in the presence of cytokines	UNSPECIFIED SUBSTANCE	35e8aec3

Showing 1 to 1 of 1 entries

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
HLA TYPED	BIOLOGICAL	MATCHED

Showing 1 to 1 of 1 entries